scholarly journals Response to the letter commenting on ʻEffect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic reviewʼ

2020 ◽  
Vol 138 ◽  
pp. 232-233
Author(s):  
Erik E.L. Jansen ◽  
Nadine Zielonke ◽  
Andrea Gini ◽  
Ahti Anttila ◽  
Nereo Segnan ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Cancer Mortality ◽  
Cervical Cancer Mortality

scholarly journals Effectiveness of Cervical Cancer Screening Over Cervical Cancer Mortality Among Japanese Women

2006 ◽  
Vol 36 (8) ◽  
pp. 511-518 ◽  
Author(s):  
Khandoker Aklimunnessa ◽  
Mitsuru Mori ◽  
M. M. H. Khan ◽  
Fumio Sakauchi ◽  
Tatsuhiko Kubo ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Cancer Mortality ◽  
Japanese Women ◽  
Cervical Cancer Mortality

scholarly journals Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review

2020 ◽  
Vol 127 ◽  
pp. 207-223 ◽  
Author(s):  
Erik E.L. Jansen ◽  
Nadine Zielonke ◽  
Andrea Gini ◽  
Ahti Anttila ◽  
Nereo Segnan ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Cancer Mortality ◽  
Cervical Cancer Mortality

Family-Centered Sexual Health Intervention to Promote Cervical Cancer Screening Uptake Among Low-income Rural Women in India: A Community-Based Protocol study (Preprint)

2021 ◽  
Author(s):  
Mandana Vahabi ◽  
Aisha K Lofters ◽  
Gauravi Mishra ◽  
Sharmila Pimple ◽  
Josephine Pui-Hing Wong
Keyword(s):  
Cervical Cancer ◽  
Health Literacy ◽  
Cancer Screening ◽  
Sexual Health ◽  
Cervical Cancer Screening ◽  
Cancer Mortality ◽  
Pap Test ◽  
Community Based ◽  
Cervical Cancer Mortality ◽  
Family Centered

BACKGROUND Human papillomavirus (HPV) is the primary cause of cervical cancer, which is preventable through screening and early treatment. The Papanicolaou (Pap) test and visual inspection with acetic acid (VIA), traditionally performed at the clinical setting, have been used effectively to screen for cervical cancer and pre-cancerous changes, and reduce cervical cancer mortality in high-income countries for many decades. However, these screening methods are not easily accessible to women living in low- and middle- income countries (LMIC), especially women living in rural areas. OBJECTIVE Preventing Cervical Cancer in India through Self-Sampling (PCCIS) is a community-based family-centered research project that aims to reduce avoidable cervical cancer disparities in rural area in India. The project will use HPV self-sampling, supported by a sexual health literacy intervention to increase rural women’s participation in cervical cancer screening. The objectives are to determine the effectiveness of this program in: (a) increasing sexual health literacy; (b) reducing gendered stigma of HPV and cervical cancer; (c) promoting cervical cancer screening using HPV self-sampling. METHODS We will recruit 120 women aged 30-69, who are under or never screened (UNS) for cervical cancer along with 120 supportive male relatives or friends from 3 impoverished rural / tribal villages in Palghar district in the state of Maharashtra, India. Participants will attend gender-specific sexual health education (SHE) followed by a Movie Matinee. Data will be collected though an interviewer-administered questionnaire before and after SHE. The questionnaire will include items on social demographics, medical history, attitudes, sexual health stigma, cervical cancer knowledge, and screening practices. Women will self-select whether to use HPV self-sampling. Those who do not may or may not undergo Pap test/VIA. Participants’ views regarding barriers and facilitators and suggestions to improve access and uptake will also be elicited. RESULTS PCCIS was funded in January 2020 for 15 months. Due to the COVID19 pandemic, the project was extended by one year. The protocol was approved by the research ethics boards of Ryerson University (REB 2020-104) and Tata Memorial Center (OIEC/3786/2021 /00003). Study outcome measures will include changes in knowledge/attitudes about cervical cancer screening, proportion of participants who self-select into each cohort, proportion of positive test result in each cohort- and proportion of participants with confirmed cervical cancer. Women’s experiences related to barriers and facilitators associated with the screening uptake will be captured. CONCLUSIONS This multi-faceted work could lead to reduced cervical cancer mortality and morbidity, and increased community capacity in sexual health promotion and cervical cancer prevention. Insights and lessons learned from this project can be used to inform the adaptation and scale-up of HPV self-sampling among women across India and in other countries, promote collective commitment to family-centred wellness, and support women to make healthful, personalized cervical screening decisions. CLINICALTRIAL Not Applicable

scholarly journals Canadian cancer screening disparities: a recent historical perspective

2015 ◽  
Vol 22 (2) ◽  
pp. 156 ◽  
Author(s):  
J. Kerner ◽  
J. Liu ◽  
K. Wang ◽  
S. Fung ◽  
C. Landry ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cervical Cancer ◽  
Cancer Screening ◽  
Cervical Cancer Screening ◽  
Colorectal Cancer Screening ◽  
Low Income ◽  
Cancer Mortality ◽  
Pap Test ◽  
Screening Programs ◽  
Screening Services

Across Canada, introduction of the Pap test for cervical cancer screening, followed by mammography for breast cancer screening and, more recently, the fecal occult blood test for colorectal cancer screening, has contributed to a reduction in cancer mortality. However, another contribution of screening has been disparities in cancer mortality between certain populations. Here, we explore the disparities associated with breast and cervical cancer screening and preliminary data concerning disparities in colorectal cancer screening.Although some disparities in screening utilization have been successfully reduced over time (for example, mammography and Pap test screening in rural and remote populations), screening utilization data for other populations (for example, low-income groups) clearly indicate that disparities have existed and continue to exist across Canada. Organized screening programs in Canada have been able to successfully engage 80% of women for regular cervical cancer screening and 70% of women for regular mammography screening, but of the women who remain to be reached or engaged in regular screening, those with the least resources, those who are the most isolated, and those who are least culturally integrated into Canadian society as a whole are overrepresented. Population differences are also observed for utilization of colorectal cancer screening services.The research literature on interventions to promote screening utilization provides some evidence about what can be done to increase participation in organized screening by vulnerable populations. Adaption and adoption of evidence-based screening promotion interventions can increase the utilization of available screening services by populations that have experienced the greatest burden of disease with the least access to screening services.

scholarly journals 323Breast and cervical cancer screening and outcomes in NSW mental health service consumers

2021 ◽  
Vol 50 (Supplement_1) ◽  
Author(s):  
Elizabeth Wilson ◽  
Hanna Tervonen ◽  
David Currow ◽  
Grant Sara
Keyword(s):  
Mental Health ◽  
Cervical Cancer ◽  
Mental Illness ◽  
Cancer Screening ◽  
Mental Health Services ◽  
Health Services ◽  
Cervical Cancer Screening ◽  
Cancer Mortality ◽  
Mental Health Problems ◽  
Research Translation

Abstract Focus of Presentation This presentation describes methods and findings from the NSW Mental Health Living Longer (MHLL) Program. MHLL involves population-wide data linkage that combines records from nine NSW data collections. Our collection includes over 120 million records for more than nine million people. This presentation focuses on the use of linked data to develop indicators to support reporting on premature cancer mortality for people living with mental illness. We will use these indicators to identify variation in care, assess areas for targeted intervention, and evaluate the effectiveness of research translation into safer and more effective care. Findings This work will be finalised by August 2020. We will use regression techniques to examine predictors of participation in breast and cervical cancer screening for women who use mental health services in NSW. These results will be used to assess geographical variation in risk-adjusted screening participation rates. We will also present methods and results for measuring incidence and stage at presentation, as well as 12 month and 5 year survival for women who use mental health services compared to other women in NSW. Conclusions/Implications If cancer survival is a key measure of the effectiveness of healthcare systems, then reduced survival in people with mental health problems reflects less effective health care. Improving screening and treatment services is likely to be the most important strategy for reducing the cancer mortality gap for people with mental illness. Key messages Health systems must move from recognition to action if we are to reduce premature cancer mortality in people living with mental illness.

Sign in / Sign up

Export Citation Format

Share Document